Combination immunotherapy with Survivin and luteinizing hormone-releasing hormone fusion protein in murine breast cancer model.

World J Clin Oncol · 2018 · PMC6314864 · PMID 30622927

Europe PMC DOI

hedged sentence

0.0400

closest p · 0.8× alpha

0.0400

boldest claim

The sentences

did not reach statistical significanceP = 0.04actually significant

Though LHRH(6leu)-LTB alone prevented the growth of tumor size in comparison to control group mice but did not reach statistical significance, inhibition was more significant with Survivin alone ( P = 0.04).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.